0pengikut
2007madeg
Babagan VACCINOGEN INC
Vaccinogen Inc. is a US biotechnology company based in Baltimore. It is currently developing a potential cancer immunotherapy called OncoVAX, where a patient's own tumor cells are used as the vaccine, adjuvanted by BCG. This product was evaluated in Phase III in colon cancer in the 1990s and another Phase III study, called ACTIVE, is currently recruiting stage II colon cancer patients. Vaccinogen calls its approach 'Active Specific Immunotherapy' or ASI.
Source: Wikipedia
IndustriBiotechnology
Kantor pusatFrederick, MD
Ngadeg2007
Bentuk hukumC Corporation
StatusAktif
Ulasan
Durung ana ulasan. Wis kerja karo VACCINOGEN INC? Dadi sing pisanan mbage pengalaman.
Angka utama
Mlebu kanggo ndeleng angka-angka utama
Pendapatan, bathi resik, lan jumlah karyawan VACCINOGEN INC saben taun, kanthi sumbere.
Mlebu Gawe akun nganggo email sampeyanGratis
Kanthi nerusake, sampeyan setuju karo Perjanjian Pangguna, Kabijakan Privasi, lan Kabijakan Cookie Heelky.
Informasi hukum
| Jeneng hukum | VACCINOGEN INC |
|---|---|
| Bentuk hukum | C Corporation |
| SEC CIK | 1453001Deleng ing SEC EDGAR ↗ |
| Alamat kadhaftar | Frederick, MD |
| Status | Aktif |
Sumber: SEC EDGAR · dianyari Nov. 14, 2026
Kontak & tautan
Lokasi
Frederick, MD
Apa iki perusahaan sampeyan?
Klaim kaca iki gratis kanggo nambah logo, produk, foto, lan kerja, lan kanggo mangsuli ulasan.
Klaim kaca ikiGabung Heelky kanggo nyambung, nyewa, lan tuwuh
Gawe akun gratis kanggo ngirim pesen, nglamar kerja, lan ngirim misi.
Gabung saiki — gratis